- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
PHARMACEUTICALS
6:47pm
HEALTH CARE
11:29pm
US regulator approves first bionic eye
Device to offer limited sight to victims of genetic eye disease
From
WORLD
10:37pm
Badger culling unlikely to stop spread of TB
Trials could help control infections in worst-hit areas
HEALTH CARE
10:05pm
Cardinal in $2bn AssuraMed home care deal
Remote care increasingly important due to Obama incentives
PHARMACEUTICALS
Feb 14, 2013
Adult demand for ADD drug lifts Shire
Sales rise 12% despite generic competition
From
RETAIL & CONSUMER
Feb 14, 2013
Britvic and AG Barr defy merger setback
Soft drinks groups push on with plan despite probe
From
RETAIL & CONSUMER
Feb 13, 2013
Reckitt gets taste for Chinese remedy
Oriental Medicine Company purchase helps group to diversify
From
INDUSTRIALS
Feb 12, 2013
Olympus trims full-year outlook
Digital camera downturn takes toll on Japanese group
PHARMACEUTICALS
Feb 12, 2013
FDA rejects Novo Nordisk insulin remedy
Shares in Danish drugmaker fall 13% after setback
- Lex Novo Nordisk
- Video Can Novo Nordisk bounce back?
From
LEX
Feb 11, 2013
Novo Nordisk: reality check
The specialist in diabetic treatments gets hit by an FDA ruling
PHARMACEUTICALS
Feb 8, 2013
Sanofi forecasts possible earnings dip
Fourth-quarter core profits down 24%
HEALTH CARE
Feb 7, 2013
S&N solid finish outweighs weaker outlook
Good news on knee implants and wound management buoy Smith & Nephew
PHARMACEUTICALS
Feb 6, 2013
Biogen to buy Elan’s stake in MS drug
US biotechnology company to pay $3.25bn in cash for full control of Tysabri
PHARMACEUTICALS
Feb 6, 2013
GSK unveils European restructuring plans
Lucozade and Ribena drinks brands placed under review
From
LEX
Feb 6, 2013
Elan / Biogen: where are the drugs?
Biotech group needs a new strategy now more than ever
PHARMACEUTICALS
Feb 5, 2013
Campaigners welcome GSK disclosure move
Clinical study reports to be released
From
TECHNOLOGY
Feb 4, 2013
Needle-free syringe passes test on mice
Technique could improve distribution of fragile vaccines
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
CHIEF EXECUTIVE
Building Societies Association
-
Director of Operations (Deputy Chief Executive)
Housing
-
Technical Manager, Member Body Development
International Federation of Accountant
-
New Business Developer - Institutional Investors Sales
Wood Mackenzie
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Olympus: climbing a mountain
Break-up of company last year would have been a good idea